Clinical Trial Details

EORTC-62932

Back to Clinical Trials Database

Phase II study of daily oral vepeside (etoposide VP16-213) as second line treatment in advanced soft tissue sarcomas

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 07-Dec-1993
Date Step1 close: 20-Jun-1994
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 25
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number